January 03, 2019
Rose
Together, the merged companies would have nine pharmaceutical products with more than $1 billion in annual sales. The deal is expected to be completed in the third quarter.
from Health https://nyti.ms/2LMvs2a
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment